OvaScience (OVAS) Reports First Quarter 2014 Financial Results
5/8/2014 9:07:23 AM
OvaScienceSM, (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported first quarter 2014 financial results, and highlighted recent accomplishments.
“We are on track with the international launch of our first fertility treatment, AUGMENT, in select IVF clinics this year,” said Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience.
Help employers find you! Check out all the jobs and post your resume.
comments powered by